MTAP and lung cancer: For example, Su et al [86] found that loss of MTAP immunostaining was independently linked to poor patient prognosis in non‐small cell lung cancers while Abrahao‐Machado et al [87] described a significant association of MTAP staining loss with poor patient outcome in Ewing family sarcomas.